| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 09/17/2003 | CN1121413C Polypeptide compounds containing D-2-alkyltryptophan capable of promoting the release of growth hormone |
| 09/17/2003 | CN1121410C Process for preparation of N-methyl-D-phenylalanyl-N-[1-[3-[ (aminoiminomethyl)-amino]propyl]-3,3-difluoro-2-oxohexyl]-L-prolinamide |
| 09/17/2003 | CN1121384C Penicillaminamide derivative |
| 09/16/2003 | US6620911 Dolastatin 10 derivatives, of given formula; administering to infected human; useful as fungicides |
| 09/16/2003 | US6620782 compounds having Formula I are potent inhibitors of caspases and apoptotic cell death. Therefore, the inhibitors of this invention can retard or block cell death in a variety of clinical conditions in which the loss of cells, tissues or |
| 09/16/2003 | CA2215695C .beta.-sheet mimetics and use thereof as protease inhibitors |
| 09/16/2003 | CA2139233C Compounds useful as sweeteners, their preparation |
| 09/16/2003 | CA2107219C S-nitrosothiols as smooth muscle relaxants and therapeutic uses thereof |
| 09/16/2003 | CA2078759C Novel carboxyalkyl derivatives useful as inhibitors of enkephalinase and ace |
| 09/12/2003 | WO2003074546A2 Streptavidin-binding peptide |
| 09/12/2003 | WO2002082041A3 Production and use of novel peptide-based agents for use with bi-specific antibodies |
| 09/11/2003 | US20030171365 Inhibitors of the interleukin-1beta conversion enzyme; useful in treatment of inflammatory, auto-immune and neurodegenerative diseases |
| 09/11/2003 | US20030171317 Methods and compositions for reducing bacterial tolerance to antibacterials, disinfectants and organic solvents |
| 09/11/2003 | US20030171304 Pyridine-2-yl-aminoalkyl carbonyl glycyl-$g(b)-alanine and derivatives thereof |
| 09/11/2003 | US20030171298 Retroinverso polypeptides that mimic or inhibit thrombospondin |
| 09/11/2003 | US20030171289 Peptides blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis, polynucleotides encoding said peptides and methods of use thereof |
| 09/11/2003 | US20030170766 Methods and compositions for inhibiting farnesyl transferase enzyme |
| 09/11/2003 | US20030170620 Gene controlling androgen |
| 09/10/2003 | EP1341819A2 Peptides and/or proteins and use thereof for the production of a therapeutic and/or prophylactic medicament |
| 09/10/2003 | EP1341767A2 Imidazole and benzimidazole caspase inhibitors and uses thereof |
| 09/10/2003 | EP1341531A2 Lactam compound to inhibit beta-amyloid peptide release or synthesis |
| 09/10/2003 | EP1296948B1 Novel gamma crystalline form of perindopril tert-butylamine salt, preparation method, and pharmaceutical compositions containing same. |
| 09/10/2003 | EP1157987B1 S-nitrosothiols as agents for the treatment of circulatory dysfunctions |
| 09/10/2003 | EP0783299B1 Compounds and compositions for delivering active agents |
| 09/10/2003 | CN1441806A Macrocyclic NS3-serine protease inhibitors of hepatitis C virus comprising N-cyclic P2 moieties |
| 09/10/2003 | CN1441785A Tetrahydroixoquinoline analogs useful as growth hormone secretagogues |
| 09/10/2003 | CN1441784A Thrombin inhibitors comprising aminoisoquinoline group |
| 09/10/2003 | CN1440971A Vitronectin receptor antagnist, its preparation and use |
| 09/09/2003 | US6617426 Peptide analogs of given formula; useful in treating neurodegenerative, autoimmune, cognitive disorders, stroke and traumatic injury |
| 09/09/2003 | US6617320 Protease inhibitor; anticoagulants |
| 09/09/2003 | US6617317 Boronic ester and acid compositions |
| 09/09/2003 | US6617310 Phosphate esters of bis-amino acid sulfonamides containing substituted benzyl amines |
| 09/09/2003 | US6617309 Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease |
| 09/09/2003 | US6617127 Synthesis and recovery of aspartame involving enzymatic deformylation step |
| 09/09/2003 | US6617110 Cultured cell comprising a nucleic acid sequence, encoding the protein, that hybridizes to a polynucleotide of given sequence; use to determine if drug is cytotoxic; can use as anticarcinogenic agent |
| 09/09/2003 | CA2290712C Novel pyridonecarboxylic acid derivatives or their salts, and antibacterial agents containing the same as their effective components |
| 09/09/2003 | CA2187901C Improved method for the preparation of an aspartame-derived compound useful as a sweetener |
| 09/09/2003 | CA2130174C 4-oxo-2 thioxoimidazolidine derivatives as inhibitors of blood platelet aggregation |
| 09/09/2003 | CA2036770C Inhibitors of nitric oxide biosynthesis |
| 09/04/2003 | WO2003072754A2 Conjugates of ligand, linker and cytotoxic agent and related compositions and methods of use |
| 09/04/2003 | WO2003072735A2 Use of peptide-drug conjugation to reduce inter-subject variability of drug serum levels |
| 09/04/2003 | WO2003072556A1 Glutaminyl based dpiv inhibitors |
| 09/04/2003 | WO2003072528A2 (substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases |
| 09/04/2003 | WO2003072034A2 Cyclic peptides and analogs useful to treat allergies |
| 09/04/2003 | WO2003071933A2 Novel compositions and methods for cancer |
| 09/04/2003 | WO2003062267A3 Enzyme substrates for the determination of activity of staphylococcus sp. extracellular protease |
| 09/04/2003 | WO2003002593A3 Peptide structures useful for competitive modulation of dipeptidyl peptidase iv catalysis |
| 09/04/2003 | WO2002032376A3 Bile-acid conjugates for providing sustained systemic concentrations of drugs |
| 09/04/2003 | WO2002020769A9 Human and mouse targeting peptides identified by phage display |
| 09/04/2003 | US20030166944 TRH-like peptide derivatives as inhibitors of the TRH-degrading ectoenzyme |
| 09/04/2003 | US20030166832 Methods and compositions for impairing multiplication of HIV-1 |
| 09/04/2003 | US20030166580 Substituted amino carboxamides for the treatment of alzheimer's disease |
| 09/04/2003 | US20030166579 Thrombin inhibitors comprising an aminoisoquinoline group |
| 09/04/2003 | US20030166577 Inhibitors for the blood-clotting factor xa |
| 09/04/2003 | US20030166576 Urokinase inhibitors |
| 09/04/2003 | US20030166575 Such as N-(toluene-4-sulfonyl)-(2S-indolin-2-carbonyl)-L-phenylalanine; integrins, cd antigens (VLA-4); antiinflammatory agents |
| 09/04/2003 | US20030166574 1,3,4-Oxadiazoline derivatives and drugs containing these derivatives as active ingredient |
| 09/04/2003 | US20030166573 Such as (2S)-N-((2S)-4-methyl-1-(5-(1-methylethylthio)1,3,4-oxadiazol-2-yl)-1-oxo-2 -pentyl)-2-benzyloxycarbonylamino-4-methylpentanamide for inhibition of cysteine proteases; antiinflammatory agents |
| 09/04/2003 | US20030166572 2-Amino-3-hydroxy-4-tert-leucyl-amino-5 phenyl-pentanoic acid amide derivatives |
| 09/04/2003 | US20030166534 Suppressing a class II MHC-restricted immune response in a mammal, or in mammalian cells, are described. The methods depend upon inhibiting invariant chain proteolysis by cathepsin S from class II MHC/invariant chain complexes, |
| 09/04/2003 | US20030166529 Polypeptides and their uses |
| 09/04/2003 | US20030166510 Methods and compositions for increasing skin remodeling |
| 09/04/2003 | US20030166506 Method of producing n-[(2S)-sulfanyl-4-(1,5,5-trimethylhydantoinyl)butanoyl]-L-leucyl-L-tert-leucine N-methylamide and intermediate thereof |
| 09/04/2003 | US20030166138 For modulating interleukin-4 receptor mediated germline epsilon transcription; for treatment of diseases associated with immunoglobulin production/accumulation |
| 09/04/2003 | US20030165427 Tuftsin metallopeptide analogs and uses thereof |
| 09/04/2003 | CA2479812A1 Glutaminyl based dpiv inhibitors |
| 09/04/2003 | CA2477225A1 Novel compositions and methods for cancer |
| 09/04/2003 | CA2477038A1 Use of peptide-drug conjugation to reduce inter-subject variability of drug serum levels |
| 09/04/2003 | CA2475653A1 (substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases |
| 09/03/2003 | EP1340762A1 Cephalosporin synthesis |
| 09/03/2003 | EP1340744A2 Hiv protease inhibitors |
| 09/03/2003 | EP1339837A2 Prolyl endoprotease from aspergillus niger |
| 09/03/2003 | EP1339746A2 Binding polypeptides for b lymphocyte stimulator protein (blys) |
| 09/03/2003 | EP1196414B1 Prodrugs of carbamate inhibitors of impdh |
| 09/03/2003 | EP1140795B1 N-3, 3-dimethylbutyl-l-aspartic acid and esters thereof, the process of preparing the same, and the process for preparing n-[n-(3,3-dimethylbutyl)-l-alpha-aspartyl)-l-phenylalanine-1-methylester therefrom |
| 09/03/2003 | EP1139794B1 CO-CRYSTALLIZATION OF SUGAR AND N- N-(3,3-DIMETHYLBUTYL)-L-alpha-ASPARTYL]-L-PHENYLALANINE 1-METHYL ESTER |
| 09/03/2003 | CN1440396A Colchinol derivatives as angiogenesis inhibitors |
| 09/03/2003 | CN1440388A Beta crystalline form of perindopril tert-butylamine salt, preparation method and pharmaceutical compositions containing same |
| 09/03/2003 | CN1440387A Alpha crystalline form of perindopril tert-butyllamine salt |
| 09/03/2003 | CN1440386A Gamma crystalline form of perindopril tert-butylamine salt, preparation method and pharmaceutical compositions containing same |
| 09/03/2003 | CN1120157C Substituted quinoline-2-carboxylic acid amidesuand their preparation and their use as medicaments and intermediate products |
| 09/02/2003 | US6613933 From N-(N-(3,3-dimethylbutyl)-L-(alpha-aspartyl)-L-phenylalanine methyl ester (APM derivative); column chromatography using a nonpolar highly porous resin |
| 09/02/2003 | US6613879 FAP-activated anti-tumour compounds |
| 09/02/2003 | US6613873 Covalently bound to a polyamide backbone; given formula; exhibit increased sequence specificity and binding affinity; resistant to enzyme degradation |
| 09/02/2003 | US6613742 Chemokine-derived synthetic peptides |
| 08/28/2003 | WO2003070967A2 Highly homogeneous molecular markers for electrophoresis |
| 08/28/2003 | WO2003070754A1 Histone deacetylase inhibitors and process for producing the same |
| 08/28/2003 | WO2003070753A1 Method for producing a powder inhalant containing a salt of the cgrp antagonist bibn4096 |
| 08/28/2003 | WO2003070751A2 Partial peptide mimetics and methods |
| 08/28/2003 | WO2003070735A2 Components for producing amphoteric liposomes |
| 08/28/2003 | WO2003070690A2 Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative |
| 08/28/2003 | WO2003031467A3 Amino-substituted camptothecin polymer derivatives and use of the same for the manufacture of a medicament |
| 08/28/2003 | WO2003016335A3 Irreversible cysteine protease inhibitors of legumain |
| 08/28/2003 | WO2003010142A3 A process for the preparation of perindopril, its analgous compounds and salts thereof using 2,5 -dioxo-oxazolidine intermediate compounds |
| 08/28/2003 | WO2002097044A3 Alternative splice forms of proteins as basis for multiple therapeutic modalities |
| 08/28/2003 | WO2002074293A3 Methods for restoring cognitive function following systemic stress |
| 08/28/2003 | WO2002034765A3 us0130034IDIC TRYPTASE SUBSTRATES AND ASSAY FOR TRYPTASE ACTIVITY USING SAME |
| 08/28/2003 | US20030163004 Reacting a benzaldehyde derivative with acetaldehyde in the presence of an alkali to produce a cinnamaldehyde derivative |
| 08/28/2003 | US20030162964 Benzene-fused heterocycle derivatives and drugs containing the same as the active ingredient |
| 08/28/2003 | US20030162820 Heterocyclic amides used as dipeptidyl aminopeptidase (DPIV) inhibitors, for prophylaxis of arthritis, obesity, allograft surgery, cancer, autoimmune, nervous system and skin disorders |